分子標的療法のためのバイオマーカー検査の有効性と利用可能性改善のためにはより良い根拠と監視が必要

Better Evidence, Oversight Needed to Improve Effectiveness and Availability of Biomarker Tests for Molecularly Targeted Therapies, Says New Report
March 4, 2016
http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=21860